Skip to main content

Table 4 Clinical performance of some biomarkers combinations in predicting all cause ICU mortality

From: Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis

  AUROCC [95 % CI] Se (%) [95 % CI] Sp (%) [95 % CI] PPV (%) [95 % CI] NPV (%) [95 % CI] Positive LR [95 % CI] Negative LR [95 % CI]
sTREM-1 (>954.4 ng/L) & PCT (>11.1 ug/L) 0.64 [0.54–0.73] 38.2 % [25.4–52.3] 89.4 % [83.1–93.9] 58.3 % [35.6–73.2] 78.7 % [75.6–85.4] 3.59 [1.50–8.57] 0.69 [0.51–0.90]
sTREM-1 (>954.4 ng/L) & Lactate (>3.2 mmol/L) 0.62 [0.53–0.72] 29.1 % [17.6–42.9] 95.7 % [91.0–98.4] 49.2 % [29.7–72.5] 83.8 % [79.7–86.2] 6.84 [1.95–26.80] 0.74 [0.58–0.90]
  1. AUROCC area under receiver operating characteristics curve, Se sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, LR likelihood ratio, PCT procalcitonin, sTREM-1 soluble triggering receptor expressed on myeloid cells-1, ICU intensive care unit